By merging real‑time multimodal imaging with AI and navigation tools, Mass General Brigham is lowering surgical complications and accelerating the shift toward personalized, less invasive cancer treatment across the healthcare industry.
Mass General Brigham is showcasing its Image‑Guided Therapy platform, anchored by a multimodality suite that offers immediate MRI, CT, ultrasound and fluoroscopy access. The facility, operational since 2011, aims to make surgeries, radiation oncology and interventional radiology more precise, efficient and minimally invasive.
The program highlights several breakthroughs: molecular profiling and real‑time imaging for prostate biopsies, mass spectrometry‑driven functional mapping in neurosurgery, MRI‑guided breast‑conserving surgery that slashes positive‑margin rates, and the Amigo Suite navigation system that pinpoints sub‑centimeter lung nodules with adequate margins. Computational imaging teams have built algorithms and hardware to improve tumor localization, while tracking technologies compensate for tissue motion during therapy.
Clinicians cite concrete outcomes—MRI‑guided breast procedures now require fewer repeat surgeries, and lung‑cancer resections achieve higher safety margins. The deep‑learning group powers AI‑driven decision support, and devices like 3D Slicer and Open IGT link imaging to real‑time instrument guidance, delivering unprecedented procedural precision.
These advances position Mass General Brigham as a benchmark for precision medicine, promising lower complication rates, shorter hospital stays and scalable models for other health systems seeking to integrate advanced imaging into routine care.
Comments
Want to join the conversation?
Loading comments...